Development of an FAP-Targeted PET Probe Based on a Novel Quinolinium Molecular Scaffold
Bioconjugate Chemistry · 2024
DOI: 10.1021/acs.bioconjchem.4c00214 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, 2024. Verfasst von Lei Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 201203, China. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Gallium Radioisotopes. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China, Gansu Science and Technology Major Project.
Abstract (Originalsprache)
Fibroblast activation protein (FAP) has recently gained significant attention as a promising tumor biomarker for both diagnosis and therapeutic applications. A series of radiopharmaceuticals based on fibroblast activation protein inhibitors (FAPIs) have been developed and translated into the clinic. Though some of them such as radiolabeled FAPI-04 probes have achieved favorable in vivo imaging performance, further improvement is still highly desired for obtaining radiopharmaceuticals with a high theranostics potential. In this study, we innovatively designed an FAPI ligand SMIC-3002 by changing the core quinoline motif of FAPI-04 to the quinolinium scaffold. The engineered molecule was further radiolabeled with 68Ga to generate a positron emission tomography (PET) probe, [68Ga]Ga-SMIC-3002, which was then evaluated in vitro and in vivo. [68Ga]Ga-SMIC-3002 demonstrated high in vitro stability, nanomolar affinity for FAP (8 nM for protein, 23 nM for U87MG cells), and specific uptake in FAP-expressing tumors, with a tumor/muscle ratio of 19.1 and a tumor uptake of 1.48 ± 0.03 ID/g% at 0.5 h in U87MG tumor-bearing mice. In summary, the quinolinium scaffold can be successfully used for the development of the FAP-targeted tracer. [68Ga]Ga-SMIC-3002 not only shows high potential for clinical translation but also offers insights into designing a new generation of FAPI tracers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 201203, China.
- State Key Laboratory of Drug Research, Molecular Imaging Center, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
- University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, China.
- Department of Nuclear Medicine, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200235, China.
- Institute of Molecular Medicine, College of Life and Health Sciences, Northeastern University, Shenyang 110167, China.
- Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
ORCID-Profile: Lei Li, Rui Cao, Zhijian Xu, Shaoli Song, Weiliang Zhu, Zhen Cheng
Förderung
- Science and Technology Commission of Shanghai Municipality
- National Natural Science Foundation of China
- Gansu Science and Technology Major Project
- Shandong Laboratory Program
Zitieren
APA
Li, L., Cao, R., Chen, K., Qu, C., Qian, K., Lin, J., Li, R., Lai, C., Wang, X., Han, Z., Xu, Z., Zhou, L., Song, S., Zhu, W., & Cheng, Z. (2024). Development of an FAP-Targeted PET Probe Based on a Novel Quinolinium Molecular Scaffold. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.4c00214
Vancouver
Li L, Cao R, Chen K, Qu C, Qian K, Lin J, et al. Development of an FAP-Targeted PET Probe Based on a Novel Quinolinium Molecular Scaffold. Bioconjugate Chemistry. 2024. doi:10.1021/acs.bioconjchem.4c00214
BibTeX
@article{Li2024,
author = {Li, Lei and Cao, Rui and Chen, Kaixin and Qu, Chunrong and Qian, Kun and Lin, Jia and Li, Renda and Lai, Chaoquan and Wang, Xiao and Han, Zijian and Xu, Zhijian and Zhou, Liping and Song, Shaoli and Zhu, Weiliang and Cheng, Zhen},
title = {Development of an FAP-Targeted PET Probe Based on a Novel Quinolinium Molecular Scaffold},
journal = {Bioconjugate Chemistry},
year = {2024},
doi = {10.1021/acs.bioconjchem.4c00214}
}
EUVIMED